|

Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes

RECRUITINGN/ASponsored by University of North Carolina, Chapel Hill
Actively Recruiting
PhaseN/A
SponsorUniversity of North Carolina, Chapel Hill
Started2025-01-22
Est. completion2026-02-01
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
Locations2 sites

Summary

The purpose of this 6-month randomized clinical trial is to examine the feasibility of recruitment, attendance, retention, program adherence, and satisfaction of a digital application designed, Centering Appetite to improve glucose scores (HbA1c) and binge eating in African American adults with type 2 diabetes. Intervention participants will receive type 2 diabetes education and web-based lessons on appetite self-regulation. Participants will also receive a Fitbit to monitor daily physical activity. The investigators will follow up with participants at six months.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

Individuals are eligible if they

* identify as a Non-Hispanic, AA
* are over 18 years of age
* have an A1c value \> 7.5
* have a working Smartphone
* complete binge eating screening

Exclusion Criteria:

Individuals will be excluded if they:

* have major end-organ type 2 diabetes mellitus complications
* have a history of weight loss surgery
* are currently pregnant
* in substance use treatment or are involved in another weight reduction program.

Conditions3

Binge EatingDiabetesType 2 Diabetes

Locations2 sites

Rachel W. Goode
Kannapolis, North Carolina, 28081
Rachel Goode, PhD, MPH, LCSW919-962-6429rwgoode@email.unc.edu
UNC Nutrition Research Institute
Kannapolis, North Carolina, 28081
Tyisha Harper-Cooks, MBA7042505093tyharper@email.unc.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.